(0.07%) 5 472.98 points
(0.11%) 39 155 points
(0.38%) 17 784 points
(0.10%) $80.91
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.23%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.69%) $10.68
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate...
Stats | |
---|---|
今日成交量 | 87 454 |
平均成交量 | 173 140 |
市值 | 70.04M |
EPS | $-0.210 ( Q1 | 2024-05-13 ) |
下一个收益日期 | ( $-0.190 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.050 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00800 (0.61%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-07 | Wills Robert James | Buy | 30 000 | Stock Option (right to buy) |
2023-06-07 | Tomsicek Michael John | Buy | 30 000 | Stock Option (right to buy) |
2023-06-07 | Pasternak Richard C | Buy | 30 000 | Stock Option (right to buy) |
2023-06-07 | Liebert Debra K. | Buy | 30 000 | Stock Option (right to buy) |
2023-06-07 | Giles Lisa M. | Buy | 30 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
1.25 |
Last 95 transactions |
Buy: 18 033 611 | Sell: 4 881 578 |
音量 相关性
Milestone Pharmaceuticals 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Milestone Pharmaceuticals 相关性 - 货币/商品
Milestone Pharmaceuticals 财务报表
Annual | 2023 |
营收: | $1.00M |
毛利润: | $402 000 (40.20 %) |
EPS: | $-1.390 |
FY | 2023 |
营收: | $1.00M |
毛利润: | $402 000 (40.20 %) |
EPS: | $-1.390 |
FY | 2022 |
营收: | $5.00M |
毛利润: | $4.52M (90.40 %) |
EPS: | $-1.350 |
FY | 2021 |
营收: | $15.00M |
毛利润: | $15.00M (100.00 %) |
EPS: | $-1.460 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。